Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
- 31 October 2021
- journal article
- research article
- Published by Elsevier BV in Infection, Genetics and Evolution
- Vol. 95, 105038
- https://doi.org/10.1016/j.meegid.2021.105038
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in EnglandScience, 2021
- Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodiesCell Host & Microbe, 2021
- Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralizationCell Host & Microbe, 2021
- The effect of spike mutations on SARS-CoV-2 neutralizationCell Reports, 2021
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variantsNature, 2021
- Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited seraNature Medicine, 2021
- Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to December 2020Eurosurveillance, 2021
- Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, ColombiaEmerging Infectious Diseases, 2020
- Immunological considerations for COVID-19 vaccine strategiesNature Reviews Immunology, 2020